{"id":61185,"date":"2026-02-09T13:53:55","date_gmt":"2026-02-09T08:23:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=61185"},"modified":"2026-02-09T13:53:57","modified_gmt":"2026-02-09T08:23:57","slug":"bliss-gvs-pharma-q3-results-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/","title":{"rendered":"Bliss GVS Pharma Gears Up for Q3 Reveal on 10th February; Check Key Expectations Here"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Q3 Results&nbsp;<\/em><\/strong><\/a><\/p><p>Bliss GVS Pharma&#8217;s Q3 results FY26 are scheduled to be announced on 10th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/#Bliss_GVS_Pharma_Q3_Results_2026_Preview\" title=\"Bliss GVS Pharma Q3 Results 2026 Preview\">Bliss GVS Pharma Q3 Results 2026 Preview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/#Bliss_GVS_Pharma_Share_Performance\" title=\"Bliss GVS Pharma Share Performance&nbsp;\">Bliss GVS Pharma Share Performance&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/#About_Bliss_GVS_Pharma\" title=\"About Bliss GVS Pharma\">About Bliss GVS Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/#Key_Factors_to_Watch_for_Bliss_GVS_Pharma_Q3_Results_FY26\" title=\"Key Factors to Watch for Bliss GVS Pharma Q3 Results FY26\">Key Factors to Watch for Bliss GVS Pharma Q3 Results FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/#Final_Thoughts\" title=\"Final Thoughts\">Final Thoughts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q3-results-expectations\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Q3_Results_2026_Preview\"><\/span><strong>Bliss GVS Pharma Q3 Results 2026 Preview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Bliss GVS Pharma&#8217;s revenue is expected to be in the range of \u20b9210.42 crore, a 3.34% YoY decrease.\u00a0<\/li>\n\n<li>Profit After Tax, or PAT, is projected to rise 3% YoY.\u00a0<\/li>\n\n<li>Net profit is \u20b923.80 crore, a rise 3% YoY\u00a0<\/li>\n\n<li>EBITDA to fall 35.53%<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Share_Performance\"><\/span><strong>Bliss GVS Pharma Share Performance&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Over the past six months, Bliss GVS Pharma&#8217;s share price has risen by 15.61% to \u20b9200.00.<\/li>\n\n<li>Moreover, over the past year, the stock has increased by 34.52%.<\/li>\n\n<li>Despite this weak short-term performance, Bliss GVS Pharma&#8217;s stock has delivered a financially sound 10.97% return over the past 5 years.<\/li>\n\n<li>As of 9th February 2026, the stock traded at \u20b9200.75 per share.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Bliss_GVS_Pharma\"><\/span><strong>About Bliss GVS Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra, engaged in the development, manufacturing, marketing, and export of pharmaceutical formulations for both domestic and global markets. Bliss GVS Pharma increased revenue by \u20b9846 crore, operating income by \u20b997.76 crore, and net income by \u20b990.26 crore. During the same period, total assets increased by \u20b91,300.84 crore<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Factors_to_Watch_for_Bliss_GVS_Pharma_Q3_Results_FY26\"><\/span><strong>Key Factors to Watch for Bliss GVS Pharma Q3 Results FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Revenue Growth: Trend in domestic and export sales across key therapeutic segments.<br><\/li>\n\n<li>Operating Margins: Stability or improvement in margins amid raw material and compliance costs.<br><\/li>\n\n<li>Profit Quality: Share of core operating profit versus other income in overall earnings.<br><\/li>\n\n<li>Export Performance: Growth in overseas markets and regulatory approvals for new geographies.<br><\/li>\n\n<li>Cost Control: Management of manufacturing, employee, and logistics expenses.<br><\/li>\n\n<li>Working Capital &amp; Cash Flow: Movement in receivables, inventory, and operating cash flows.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Final_Thoughts\"><\/span><strong>Final Thoughts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Bliss GVS Pharma will announce its Q3 FY26 results on 10th February 2026. Analysts expect 3.34% revenue growth, a 3% rises in PAT, and a 35.53% fall in EBITDA. Bliss GVS Pharma&#8217; sales bookings recovery, timely project deliveries, and margin stability are supported by strong customer collections.<\/p><p><em>Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/alfred-herbert-india-q3-results-expectations\"><strong>Alfred Herbert India Ltd Q3 Results FY26 Preview: PAT falls 3%<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/salora-international-q3-results-expectations\"><strong>Salora International Q3 Results FY26 Preview: PAT falls 18.54%<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/kuantum-papers-q3-results-expectations\"><strong>Kuantum Papers Q3 Results FY26 Preview: PAT falls 29.85%<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/ak-capital-services-q3-results-expectations\"><strong>AK Capital Services Ltd Q3 Results FY26 Preview: PAT falls 16.86%<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/glance-finance-q3-results-expectations\"><strong>Glance Finance Q3 Results FY26 Preview: PAT rises 58.48%<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Live Updates on Q3 Results&nbsp; Bliss GVS Pharma&#8217;s Q3 results FY26 are scheduled to be announced on 10th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT. Bliss GVS Pharma Q3 Results 2026 Preview Bliss GVS Pharma Share Performance&nbsp;<\/p>\n","protected":false},"author":27,"featured_media":61186,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3800,3801],"class_list":["post-61185","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-q3-results","tag-q3-results-2026"],"metadata":{"_edit_lock":["1770625442:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["70"],"rank_math_title":["Bliss GVS Pharma Q3 Results FY26 Preview: PAT to rises 3%"],"rank_math_description":["Bliss GVS Pharma Q3 results FY26 Preview: PAT is expected to rise 3%, while we expect a 3.34% fall in Net Sales. Get detailed insights on quarterly results.   "],"rank_math_focus_keyword":["Bliss GVS Pharma Q3 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["61186"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["6298"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/09135119\/Bliss-GVS-Pharma-Q3-Results-FY26-Preview-PAT-rises-3.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/61185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=61185"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/61185\/revisions"}],"predecessor-version":[{"id":61187,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/61185\/revisions\/61187"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/61186"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=61185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=61185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=61185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}